Economic Evaluation of Changes in Reimbursement for Medications Purchased Through the 340B Drug Pricing Program
Sign Up to like & getrecommendations! Published in 2021 at "Hospital Pharmacy"
DOI: 10.1177/0018578719888907
Abstract: Background: The Centers for Medicare and Medicaid Services (CMS) implemented changes to the reimbursement scheme for 340B-acquired medications on January 1, 2018, reducing payments by approximately 25%. It was recognized that these changes would have… read more here.
Keywords: 340b drug; reimbursement; changes reimbursement; evaluation ... See more keywords